Sano Naoto, Yamashita Yoshio, Fukuda Kazumasa, Taniguchi Hatsumi, Goto Masaaki, Miyamoto Hiroshi
Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
ISRN Dent. 2012;2012:840483. doi: 10.5402/2012/840483. Epub 2012 May 22.
Intracystic fluid was aseptically collected from 11 patients with postoperative maxillary cyst (POMC), and DNA was extracted from the POMC fluid. Bacterial species were identified by sequencing after cloning of approximately 580 bp of the 16S rRNA gene. Identification of pathogenic bacteria was also performed by culture methods. The phylogenetic identity was determined by sequencing 517-596 bp in each of the 1139 16S rRNA gene clones. A total of 1114 clones were classified while the remaining 25 clones were unclassified. A total of 103 bacterial species belonging to 42 genera were identified in POMC fluid samples by 16S rRNA gene analysis. Species of Prevotella (91%), Neisseria (73%), Fusobacterium (73%), Porphyromonas (73%), and Propionibacterium (73%) were found to be highly prevalent in all patients. Streptococcus mitis (64%), Fusobacterium nucleatum (55%), Propionibacterium acnes (55%), Staphylococcus capitis (55%), and Streptococcus salivarius (55%) were detected in more than 6 of the 11 patients. The results obtained by the culture method were different from those obtained by 16S rRNA gene analysis, but both approaches may be necessary for the identification of pathogens, especially of bacteria that are difficult to detect by culture methods, and the development of rational treatments for patients with POMC.
无菌采集11例上颌窦术后囊肿(POMC)患者的囊内液体,并从POMC液体中提取DNA。对16S rRNA基因约580 bp片段进行克隆后测序,鉴定细菌种类。还通过培养方法鉴定病原菌。通过对1139个16S rRNA基因克隆中的每一个进行517 - 596 bp测序来确定系统发育同一性。共分类了1114个克隆,其余25个克隆未分类。通过16S rRNA基因分析在POMC液体样本中鉴定出总共103种属于42个属的细菌。发现普雷沃菌属(91%)、奈瑟菌属(73%)、梭杆菌属(73%)、卟啉单胞菌属(73%)和丙酸杆菌属(73%)在所有患者中高度流行。在11例患者中的6例以上检测到缓症链球菌(64%)、具核梭杆菌(55%)、痤疮丙酸杆菌(55%)、头状葡萄球菌(55%)和唾液链球菌(55%)。培养方法获得的结果与16S rRNA基因分析获得的结果不同,但两种方法对于病原菌的鉴定可能都是必要的,特别是对于难以通过培养方法检测到的细菌,以及为POMC患者制定合理的治疗方案。